PL3033327T3 - Sól (l)-(+)-winianowa (-)-(2r,3s)-2-amino-3-hydroksy-3-pirydyn-4-ylo-1-pirolidyn-1-ylo-propan-1-onu, sposoby jej produkcji i użycia - Google Patents
Sól (l)-(+)-winianowa (-)-(2r,3s)-2-amino-3-hydroksy-3-pirydyn-4-ylo-1-pirolidyn-1-ylo-propan-1-onu, sposoby jej produkcji i użyciaInfo
- Publication number
- PL3033327T3 PL3033327T3 PL14755535T PL14755535T PL3033327T3 PL 3033327 T3 PL3033327 T3 PL 3033327T3 PL 14755535 T PL14755535 T PL 14755535T PL 14755535 T PL14755535 T PL 14755535T PL 3033327 T3 PL3033327 T3 PL 3033327T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrrolidin
- propan
- pyridin
- hydroxy
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361866155P | 2013-08-15 | 2013-08-15 | |
| EP14755535.3A EP3033327B1 (en) | 2013-08-15 | 2014-08-14 | (-)-(2r,3s)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (l)-(+) tartrate salt, its method of production and use |
| PCT/US2014/051007 WO2015023816A1 (en) | 2013-08-15 | 2014-08-14 | (-)-(2r,3s)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (l)-(+) tartrate salt, its method of production and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3033327T3 true PL3033327T3 (pl) | 2018-07-31 |
Family
ID=51398940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14755535T PL3033327T3 (pl) | 2013-08-15 | 2014-08-14 | Sól (l)-(+)-winianowa (-)-(2r,3s)-2-amino-3-hydroksy-3-pirydyn-4-ylo-1-pirolidyn-1-ylo-propan-1-onu, sposoby jej produkcji i użycia |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US9242935B2 (enExample) |
| EP (2) | EP3336079A1 (enExample) |
| JP (1) | JP6486358B2 (enExample) |
| CN (2) | CN108794386B (enExample) |
| CA (1) | CA2921385C (enExample) |
| DK (1) | DK3033327T3 (enExample) |
| ES (1) | ES2664749T3 (enExample) |
| HU (1) | HUE036381T2 (enExample) |
| NO (1) | NO2960430T3 (enExample) |
| PL (1) | PL3033327T3 (enExample) |
| PT (1) | PT3033327T (enExample) |
| SI (1) | SI3033327T1 (enExample) |
| WO (1) | WO2015023816A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3033327T3 (en) | 2013-08-15 | 2018-04-16 | Allergan Inc | (-) - (2R, 3S) -2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L) - (+) - tartrate salt, PROCEDURE FOR MANUFACTURING AND USING THEREOF |
| US9992703B2 (en) * | 2016-04-04 | 2018-06-05 | Cisco Technology, Inc. | Insertion of management packet into a deterministic track |
| JP2025506178A (ja) * | 2022-02-11 | 2025-03-07 | ギルガメッシュ・ファーマシューティカルズ・インコーポレイテッド | 精神状態及び障害を処置するための（ａｍｐａｒ－ｐａｍ）－ｎｍｄａ受容体拮抗薬組合せ療法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5545745A (en) * | 1994-05-23 | 1996-08-13 | Sepracor, Inc. | Enantioselective preparation of optically pure albuterol |
| US6835831B2 (en) * | 2001-11-26 | 2004-12-28 | Genzyme Corporation | Diastereoselective synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| US20090088433A1 (en) * | 2005-01-26 | 2009-04-02 | Bertrand Leblond | Methods of using as analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| WO2008011478A2 (en) * | 2006-07-19 | 2008-01-24 | Allergan, Inc. | Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| WO2008011483A2 (en) * | 2006-07-19 | 2008-01-24 | Allergan, Inc. | Methods for treating chronic pain using 1- (hetero) aryl-1-hydroxy 2,3-diamino-propyl amines and related compounds |
| DK2481407T3 (en) * | 2007-03-06 | 2019-01-07 | Allergan Inc | RELATIONSHIPS TO USE IN TREATMENT OF COGNITIVE DISORDERS |
| US8173683B2 (en) * | 2007-03-06 | 2012-05-08 | Allergan, Inc. | Methods for treating cognitive disorders |
| US20100105687A1 (en) * | 2007-03-06 | 2010-04-29 | Allergan, Inc. | Methods for treating cognitive disorders using 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds |
| DK3033327T3 (en) | 2013-08-15 | 2018-04-16 | Allergan Inc | (-) - (2R, 3S) -2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L) - (+) - tartrate salt, PROCEDURE FOR MANUFACTURING AND USING THEREOF |
-
2014
- 2014-08-14 DK DK14755535.3T patent/DK3033327T3/en active
- 2014-08-14 US US14/459,551 patent/US9242935B2/en active Active
- 2014-08-14 WO PCT/US2014/051007 patent/WO2015023816A1/en not_active Ceased
- 2014-08-14 SI SI201430670T patent/SI3033327T1/en unknown
- 2014-08-14 JP JP2016534827A patent/JP6486358B2/ja active Active
- 2014-08-14 CN CN201810276093.9A patent/CN108794386B/zh active Active
- 2014-08-14 CA CA2921385A patent/CA2921385C/en active Active
- 2014-08-14 EP EP18150038.0A patent/EP3336079A1/en not_active Withdrawn
- 2014-08-14 CN CN201480050583.7A patent/CN105555765B/zh active Active
- 2014-08-14 EP EP14755535.3A patent/EP3033327B1/en active Active
- 2014-08-14 PT PT147555353T patent/PT3033327T/pt unknown
- 2014-08-14 ES ES14755535.3T patent/ES2664749T3/es active Active
- 2014-08-14 HU HUE14755535A patent/HUE036381T2/hu unknown
- 2014-08-14 PL PL14755535T patent/PL3033327T3/pl unknown
-
2015
- 2015-06-26 NO NO15174003A patent/NO2960430T3/no unknown
- 2015-12-21 US US14/976,926 patent/US9540328B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PT3033327T (pt) | 2018-04-04 |
| EP3336079A1 (en) | 2018-06-20 |
| CN105555765A (zh) | 2016-05-04 |
| SI3033327T1 (en) | 2018-05-31 |
| US20160347712A1 (en) | 2016-12-01 |
| EP3033327B1 (en) | 2018-01-03 |
| WO2015023816A1 (en) | 2015-02-19 |
| CN108794386A (zh) | 2018-11-13 |
| JP6486358B2 (ja) | 2019-03-20 |
| EP3033327A1 (en) | 2016-06-22 |
| NO2960430T3 (enExample) | 2018-01-06 |
| DK3033327T3 (en) | 2018-04-16 |
| CN108794386B (zh) | 2021-06-22 |
| CA2921385A1 (en) | 2015-02-19 |
| JP2016528255A (ja) | 2016-09-15 |
| HUE036381T2 (hu) | 2018-07-30 |
| CN105555765B (zh) | 2018-05-25 |
| US20150051253A1 (en) | 2015-02-19 |
| ES2664749T3 (es) | 2018-04-23 |
| US9540328B2 (en) | 2017-01-10 |
| HK1224292A1 (zh) | 2017-08-18 |
| US9242935B2 (en) | 2016-01-26 |
| CA2921385C (en) | 2021-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL240475A0 (en) | Tubulin compounds, methods for their preparation and use | |
| EP2997837A4 (en) | Disintegrable capsule, manufacturing method for same, and smoking equipment containing said disintegrable capsule | |
| PL3044202T3 (pl) | Mieszaniny enancjomerów i sposób wytwarzania takich mieszanin | |
| EP3053978A4 (en) | Polishing composition and production method therefor | |
| PL3038656T3 (pl) | Związek glikozaminoglikanu, sposób wytwarzania i jego zastosowania | |
| EP3053977A4 (en) | Polishing composition and production method therefor | |
| HUE042470T2 (hu) | Eljárás széntartalmú anyagok kezelésére gõz termolízissel | |
| PL3055679T3 (pl) | Środek do wykrywania pęknięć, sposób jego wytwarzania i zastosowanie środka do wykrywania pęknięć | |
| GB2513065B (en) | Desiccant cap and method of production and use | |
| EP3079679A4 (en) | Method of treatment of alopecia with monoterpenoids | |
| GB2516425B (en) | Encoder and decoder, and method of operation | |
| ZA201503410B (en) | Method of making alpha, omega-diiodoperfluoroalkanes | |
| PL3033327T3 (pl) | Sól (l)-(+)-winianowa (-)-(2r,3s)-2-amino-3-hydroksy-3-pirydyn-4-ylo-1-pirolidyn-1-ylo-propan-1-onu, sposoby jej produkcji i użycia | |
| IL245018A0 (en) | Synthetic intermediate of mexacalcitol, method for its preparation and use | |
| IL241096A0 (en) | Treatment methods | |
| EP3023096A4 (en) | Soft capsule coating | |
| ZA201603990B (en) | Taxane compound, and preparation method and use thereof | |
| ZA201603682B (en) | Taxanes compounds, preparation method therefor, and uses thereof | |
| PL3270912T3 (pl) | Kompozycje farmaceutyczne zawierające kompleksy taksan-cyklodekstryna, sposób wytwarzania i sposoby zastosowania | |
| EP3041506A4 (en) | A method of treatment | |
| AU2013904712A0 (en) | Method of Treatment | |
| AU2013904170A0 (en) | Method of treatment | |
| AU2013901359A0 (en) | Methods of Treatment | |
| GB201322778D0 (en) | Method of treatment | |
| GB201314882D0 (en) | Method of treatment |